130 related articles for article (PubMed ID: 8747487)
21. Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: implications for Primary Hyperoxaluria type 1.
Dindo M; Grottelli S; Annunziato G; Giardina G; Pieroni M; Pampalone G; Faccini A; Cutruzzolà F; Laurino P; Costantino G; Cellini B
Biochem J; 2019 Dec; 476(24):3751-3768. PubMed ID: 31794008
[TBL] [Abstract][Full Text] [Related]
22. Primary hyperoxaluria type 1 and peroxisome-to-mitochondrion mistargeting of alanine:glyoxylate aminotransferase.
Danpure CJ
Biochimie; 1993; 75(3-4):309-15. PubMed ID: 8507692
[TBL] [Abstract][Full Text] [Related]
23. The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I.
Oppici E; Montioli R; Dindo M; Maccari L; Porcari V; Lorenzetto A; Chellini S; Voltattorni CB; Cellini B
ACS Chem Biol; 2015 Oct; 10(10):2227-36. PubMed ID: 26161999
[TBL] [Abstract][Full Text] [Related]
24. Oxalate synthesis in mammals: properties and subcellular distribution of serine:pyruvate/alanine:glyoxylate aminotransferase in the liver.
Ichiyama A; Xue HH; Oda T; Uchida C; Sugiyama T; Maeda-Nakai E; Sato K; Nagai E; Watanabe S; Takayama T
Mol Urol; 2000; 4(4):333-40. PubMed ID: 11156700
[TBL] [Abstract][Full Text] [Related]
25. Human liver L-alanine-glyoxylate aminotransferase: characteristics and activity in controls and hyperoxaluria type I patients using a simple spectrophotometric method.
Wanders RJ; Ruiter J; van Roermund CW; Schutgens RB; Ofman R; Jurriaans S; Tager JM
Clin Chim Acta; 1990 Aug; 189(2):139-44. PubMed ID: 2397596
[TBL] [Abstract][Full Text] [Related]
26. Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.
Fargue S; Knight J; Holmes RP; Rumsby G; Danpure CJ
Biochim Biophys Acta; 2016 Jun; 1862(6):1055-62. PubMed ID: 26854734
[TBL] [Abstract][Full Text] [Related]
27. Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation.
Cellini B; Montioli R; Paiardini A; Lorenzetto A; Voltattorni CB
J Biol Chem; 2009 Mar; 284(13):8349-58. PubMed ID: 19155213
[TBL] [Abstract][Full Text] [Related]
28. Translation inhibition corrects aberrant localization of mutant alanine-glyoxylate aminotransferase: possible therapeutic approach for hyperoxaluria.
Belostotsky R; Lyakhovetsky R; Sherman MY; Shkedy F; Tzvi-Behr S; Bar R; Hoppe B; Reusch B; Beck BB; Frishberg Y
J Mol Med (Berl); 2018 Jul; 96(7):621-630. PubMed ID: 29777253
[TBL] [Abstract][Full Text] [Related]
29. Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1.
Purdue PE; Takada Y; Danpure CJ
J Cell Biol; 1990 Dec; 111(6 Pt 1):2341-51. PubMed ID: 1703535
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization and clinical use of a polymorphic tandem repeat in an intron of the human alanine:glyoxylate aminotransferase gene.
Danpure CJ; Birdsey GM; Rumsby G; Lumb MJ; Purdue PE; Allsop J
Hum Genet; 1994 Jul; 94(1):55-64. PubMed ID: 8034295
[TBL] [Abstract][Full Text] [Related]
31. Molecular and clinical heterogeneity in primary hyperoxaluria type 1.
Danpure CJ
Am J Kidney Dis; 1991 Apr; 17(4):366-9. PubMed ID: 2008900
[TBL] [Abstract][Full Text] [Related]
32. Immunological heterogeneity of hepatic alanine:glyoxylate aminotransferase in primary hyperoxaluria type 1.
Wise PJ; Danpure CJ; Jennings PR
FEBS Lett; 1987 Sep; 222(1):17-20. PubMed ID: 2443389
[TBL] [Abstract][Full Text] [Related]
33. Rapid identification of primary hyperoxaluria type I patients using a novel, fully automated method for measurement of hepatic alanine: glyoxylate aminotransferase.
Horváth VA; Wanders RJ
J Inherit Metab Dis; 1994; 17(3):336-8. PubMed ID: 7807946
[No Abstract] [Full Text] [Related]
34. [Molecular pathology of type 1 primary hyperoxaluria].
Cochat P; Rolland MO; Bozon D; Dumontel C; Divry P
Nephrologie; 1994; 15(6):375-80. PubMed ID: 7862225
[TBL] [Abstract][Full Text] [Related]
35. Alanine glyoxylate aminotransferase and the urinary excretion of oxalate and glycollate in hyperoxaluria type I and the Zellweger syndrome.
Wanders RJ; van Roermund CW; Westra R; Schutgens RB; van der Ende MA; Tager JM; Monnens LA; Baadenhuysen H; Govaerts L; Przyrembel H
Clin Chim Acta; 1987 Jun; 165(2-3):311-9. PubMed ID: 3652453
[TBL] [Abstract][Full Text] [Related]
36. Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I.
Danpure CJ; Jennings PR
FEBS Lett; 1986 May; 201(1):20-4. PubMed ID: 3709805
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome localized human hepatic alanine-glyoxylate aminotransferase and its application to clinical diagnosis.
Nakatani T; Kawasaki Y; Minatogawa Y; Okuno E; Kido R
Clin Biochem; 1985 Oct; 18(5):311-6. PubMed ID: 4053344
[TBL] [Abstract][Full Text] [Related]
38. Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications.
Cellini B; Bertoldi M; Montioli R; Paiardini A; Borri Voltattorni C
Biochem J; 2007 Nov; 408(1):39-50. PubMed ID: 17696873
[TBL] [Abstract][Full Text] [Related]
39. In vivo and in vitro examination of stability of primary hyperoxaluria-associated human alanine:glyoxylate aminotransferase.
Hopper ED; Pittman AM; Fitzgerald MC; Tucker CL
J Biol Chem; 2008 Nov; 283(45):30493-502. PubMed ID: 18782763
[TBL] [Abstract][Full Text] [Related]
40. Enzymatic heterogeneity in primary hyperoxaluria type 1 (hepatic peroxisomal alanine: glyoxylate aminotransferase deficiency).
Danpure CJ; Jennings PR
J Inherit Metab Dis; 1988; 11 Suppl 2():205-7. PubMed ID: 3141703
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
